Article
Endogenous retrovirus activation: potential for immunology and clinical applications
25 Jan 2024
Abstract excerpt
Endogenous retroviruses (ERVs), the remnants of ancient retrovirus infections, constitute approximately 8% of the human genome and play important roles in human evolution, development, and diseases. Multiple drugs, such as DNA methyltransferase inhibitors and lysine-specific histone demethylase 1 inhibitors, reactivate ERVs, induce viral mimicry and trigger innate immune responses to enhance tumor immunogenicity....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
